Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy I: Introduction and Classification
Alternative RNA Splicing
Disorders of Erythrocytes
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 17, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
1Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland, thol.felicitas@mh-hannover.de.
Myelodysplastic syndromes (MDS) are stem cell disorders causing ineffective blood cell production, leading to anemia, neutropenia, and thrombocytopenia. Treatment strategies for MDS are risk-stratified, with curative options like stem cell transplantation for high-risk patients.
Area of Science: